Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease. 1985

M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda

In the treatment of cyanotic heart diseases in neonates who are ductus dependent, the small size of the pulmonary artery and/or subclavian artery often precludes construction of a sufficient Blalock-Taussig shunt. To avoid an emergency operation and to obtain pulmonary and subclavian arteries of adequate size (3 mm), a low dose of prostaglandin E1 was given to 16 neonates for a mean of 47 days (range 26 to 65 days), and a modified Blalock-Taussig shunt operation was performed in neonates whose mean age was 50 days. The pulmonary artery grew significantly (mean 4.5 mm) and the mean diameter of the subclavian artery was 3 mm, which was large enough for a good shunt at the time of operation. There were two late deaths and one operative death. All surviving patients shunts at the mean follow-up period of 22 months. The shunt was constructed on the same side as the ductus arteriosus so that the ductus could be ligated at the same operation in selected cases; the ductus may not close after discontinuation of prostaglandin E1 infusion and may cause uncontrollable congestive heart failure because of excessive pulmonary blood flow, particularly in patients with a univentricular heart. The ductus, dissected in nine patients, was enlarged and elongated in all and was ligated in four patients without complication.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D004374 Ductus Arteriosus, Patent A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth. Patent Ductus Arteriosus Familial,Patency of the Ductus Arteriosus,Patent Ductus Arteriosus
D006330 Heart Defects, Congenital Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life. Congenital Heart Disease,Heart Abnormalities,Abnormality, Heart,Congenital Heart Defect,Congenital Heart Defects,Defects, Congenital Heart,Heart Defect, Congenital,Heart, Malformation Of,Congenital Heart Diseases,Defect, Congenital Heart,Disease, Congenital Heart,Heart Abnormality,Heart Disease, Congenital,Malformation Of Heart,Malformation Of Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014661 Vasoconstriction The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE. Vasoconstrictions

Related Publications

M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
June 1979, The Annals of thoracic surgery,
M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
May 2022, Heart and vessels,
M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
February 2009, Heart, lung & circulation,
M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
February 2009, Heart, lung & circulation,
M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
May 1987, European journal of pediatrics,
M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
April 2007, Journal of cardiothoracic and vascular anesthesia,
M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
November 1987, The Japanese journal of surgery,
M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
June 1985, The Annals of thoracic surgery,
M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
January 1988, Pediatric radiology,
M Yokota, and R Muraoka, and M Aoshima, and S Nomoto, and Y Shiraishi, and I Kyoku, and M Kitano, and I Shimada, and H Nakano, and K Ueda
February 2010, Indian pediatrics,
Copied contents to your clipboard!